PTC Therapeutics Inc. Stock
Price
Target price
€28.20
€28.20
-0.700%
-0.2
-0.700%
€41.81
09.05.24 / Stuttgart Stock Exchange
WKN: A1W0MW / Symbol: PTCT / Name: PTC Therapeutics / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. shows a slight decrease today, losing -€0.200 (-0.700%) compared to yesterday.
Our community is currently high on PTC Therapeutics Inc. with 13 Buy predictions and 5 Sell predictions.
As a result the target price of 41 € shows a positive potential of 45.39% compared to the current price of 28.2 € for PTC Therapeutics Inc..
For the coming years our community has positive and negative things to say abot the PTC Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of PTC Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of PTC Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | -0.700% | -6.623% | 15.574% | -43.600% | 11.905% | -11.321% | -22.389% |
| Ironwood Pharmaceuticals | - | -1.316% | 1.351% | -19.786% | -26.471% | -18.033% | - |
| Sage Therapeutics Inc. | 0.610% | -14.738% | -27.778% | -76.979% | -44.750% | -82.131% | - |
| Novocure Ltd | -1.990% | 11.707% | 12.652% | -76.475% | 7.285% | -89.787% | - |
Comments
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Jefferies Financial Group Inc. from $33.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Show more
Ratings data for PTCT provided by MarketBeat